August 7th, 2023
Researchers at the Harvard Wyss Institute have developed an anti-cancer biomaterial treatment that combines adoptive T cell therapy and cancer vaccine technology to treat solid tumors. The researchers have called their technique SIVET, which is short for “synergistic in situ vaccination enhanced T cell”. The approach combines...
February 28th, 2023
Researchers at the Harvard Wyss Institute are collaborating with a biotechnology company called Gameto to develop human ovarian organoids that will allow the study of reproductive and other health issues using tissues that closely mimic those in human patients. Another application may lie in allowing people with fertility issues to...
July 19th, 2022
Researchers at Harvard developed a technique that lets them recreate the helical arrangement of cardiac muscle fibers within the heart ventricles in a bioengineered construct. The breakthrough could pave the way for artificial bioengineered hearts.
The researchers used a technique called Focused Rotary Jet Spinning (FRJS) that...
July 5th, 2022
Researchers at Harvard's Wyss Institute have modeled Environmental Enteric Dysfunction (EED), a childhood inflammatory intestinal disease, on a microfluidic chip and gained new insights into the genetic changes underlying the condition. This is the first in vitro model of the disease, and highlights the power of organ on a chip...
January 18th, 2021
Applying an energy source, such as a laser, to cut through or cauterize tissue is already widely used in external surgeries, such as laser eye surgery, but using this technology safely and accurately during minimally invasive internal procedures is difficult. Current endoscopic technology does not permit lasers to be steered and...